Bioeq GmbH

Since the acquisition in May 2022, Bioeq GmbH is a part of the Formycon Group and continues to be the sponsor of the ongoing clinical trials for Formycon’s biosimilar candidates.

The former Bioeq employees have meanwhile joined #TeamFormycon and contribute their expertise in clinical development, regulatory affairs, business development, commercial affairs, IP as well as project management to Formycon’s strengthened development organization.